Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder

Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer (Industry)
Overall Status
Completed
CT.gov ID
NCT00128934
Collaborator
(none)
744
83
28
9
0.3

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether levonorgestrel (LNG)/ethinyl estradiol (EE) is effective in treating the symptoms of severe premenstrual syndrome (PMS).

Condition or Disease Intervention/Treatment Phase
  • Drug: levonorgestrel/ethinyl estradiol
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
744 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Prevention
Official Title:
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of a Combination of Levonorgestrel and Ethinyl Estradiol in a Continuous Daily Regimen in Subjects With Premenstrual Dysphoric Disorder
Study Start Date :
Aug 1, 2005
Actual Study Completion Date :
Dec 1, 2007

Outcome Measures

Primary Outcome Measures

  1. Mean change in average Daily Record of Severity of Problems (DRSP) 21-item total daily score []

Secondary Outcome Measures

  1. Change from baseline in DRSP 21-item daily score based on the 5 days with the highest DRSP scores in each "estimated" treatment cycle []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 49 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Generally healthy, women aged 18 to 49 years.

  • History of severe PMS symptoms over the last year, as determined by the investigator.

  • Regular 21 to 35 day menstrual cycle for 2 months prior to first study visit.

Exclusion Criteria:
  • Major depressive disorder requiring antidepressant treatment or hospitalization within the last 3 years.

  • Contraindication to combination oral contraceptives.

  • Use of antidepressants/anxiolytics within 10 days of screening and for the duration of the study.

Other exclusions apply.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Scottsdale Arizona United States 85251
2 Tucson Arizona United States 85715
3 Jonesboro Arkansas United States 72401
4 Little Rock Arkansas United States 72205
5 Carmichael California United States 95608
6 Los Angeles California United States 90095
7 San Diego California United States 92103
8 Denver Colorado United States 80202
9 Lakewood Colorado United States 80228
10 Longmont Colorado United States 80501
11 Middletown Connecticut United States 06457
12 New Haven Connecticut United States 06510
13 Waterbury Connecticut United States 06708
14 Washington District of Columbia United States 20037
15 Adventure Florida United States 33180
16 Clearwater Florida United States 33761
17 Fort Myers Florida United States 33916
18 Hialeah Florida United States 33016
19 Pembroke Pines Florida United States 33024
20 West Palm Beach Florida United States 33407
21 Atlanta Georgia United States 30328
22 Atlanta Georgia United States 30342
23 Savannah Georgia United States 31406
24 Boise Idaho United States 83712
25 Chicago Illinois United States 60631
26 Chicago Illinois United States 60634
27 Evansville Indiana United States 47714
28 South Bend Indiana United States 46601
29 Lexington Kentucky United States 40509
30 New Orleans Louisiana United States 70114
31 Glen Burnie Maryland United States 21061
32 Boston Massachusetts United States 02114
33 Pittsfield Massachusetts United States 01201
34 Springfield Massachusetts United States 01107
35 Brooklyn New York United States 11235
36 Buffalo New York United States 14214
37 New York City New York United States 10021
38 Rochester New York United States 14609
39 Fayetteville North Carolina United States 28304
40 New Bern North Carolina United States 28562
41 Winston-Salem North Carolina United States 27103
42 Cincinnati Ohio United States 45219
43 Cleveland Ohio United States 44122
44 Mogadore Ohio United States 44260
45 Oklahoma City Oklahoma United States 73112
46 Tulsa Oklahoma United States 74135
47 Eugene Oregon United States 97401
48 Medford Oregon United States 97504
49 Philadelphia Pennsylvania United States 19104
50 Philadelphia Pennsylvania United States 19114
51 Wexford Pennsylvania United States 15090
52 East Providence Rhode Island United States 02914
53 Greer South Carolina United States 29654
54 Hilton Head Island South Carolina United States 29926
55 Nashville Tennessee United States 37203
56 Austin Texas United States 78756
57 Carrollton Texas United States 75010
58 Conroe Texas United States 77304
59 San Antonio Texas United States 78229
60 Salt Lake City Utah United States 84107
61 Sandy Utah United States 84070
62 Burlington Vermont United States 05401
63 Charlottesville Virginia United States 22903
64 Norfolk Virginia United States 23502
65 Richmond Virginia United States 23230
66 Richmond Virginia United States 23233
67 Richmond Virginia United States 23294
68 Lakewood Washington United States 98499
69 Renton Washington United States 98055
70 Edmonton Alberta Canada T6G 2C8
71 Edmonton Alberta Canada T6L 5X8
72 Kelowna British Columbia Canada V1Y 2H4
73 Vancouver British Columbia Canada V6H 3N1
74 Hamilton Ontario Canada L8N 4A6
75 Toronto Ontario Canada M9W 4L6
76 Hull Quebec Canada J9A 1K7
77 Montréal Quebec Canada H1T 1P6
78 Montréal Quebec Canada H3A 1A1
79 Pointe-Claire Quebec Canada H9R 4S3
80 Quebec City Quebec Canada G1R 2W8
81 Quebec City Quebec Canada G1S 2L6
82 Shawinigan Quebec Canada G9N 2H6
83 Sherbrooke Quebec Canada J1H 4J6

Sponsors and Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

Investigators

  • Study Director: Medical Monitor, MD, Wyeth is now a wholly owned subsidiary of Pfizer

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00128934
Other Study ID Numbers:
  • 0858A4-316
  • NCT00278720
First Posted:
Aug 10, 2005
Last Update Posted:
Dec 27, 2007
Last Verified:
Dec 1, 2007

Study Results

No Results Posted as of Dec 27, 2007